<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7673933</article-id><article-id pub-id-type="doi">10.1155/2020/8872945</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Rosanortriterpenes A&#x02013;B, Two Promising Agents from <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic>, Alleviate Inflammatory Responses and Liver Fibrosis in In Vitro Cell Models</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Li</surname><given-names>Bai-Lin</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Juan-Juan</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Xie</surname><given-names>Jin-Dan</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Ni</surname><given-names>Chen</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Liang</surname><given-names>Hui-Jun</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Qian-Ran</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author"><name><surname>Yuan</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="I1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1430-2830</contrib-id><name><surname>Wu</surname><given-names>Jie-Wei</given-names></name><email>wujiewei@gzucm.edu.cn</email><xref ref-type="aff" rid="I1"/></contrib></contrib-group><aff id="I1">Guangdong Provincial Key Laboratory of New Drug Development and Research of Chinese Medicine, Mathematical Engineering Academy of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou 510006, China</aff><author-notes><fn fn-type="other"><p>Academic Editor: Jianbo Wan</p></fn></author-notes><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>10</day><month>11</month><year>2020</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>11</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>2020</volume><elocation-id>8872945</elocation-id><history><date date-type="received"><day>11</day><month>8</month><year>2020</year></date><date date-type="rev-recd"><day>18</day><month>10</month><year>2020</year></date><date date-type="accepted"><day>24</day><month>10</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Bai-Lin Li et al.</copyright-statement><copyright-year>2020</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Rosanortriterpenes A&#x02013;B (RTA and RTB), two nortriterpenoids, are characteristic constituents in the fruits of <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic>. However, pharmacological studies on these compounds are still scarce. In the present study, we aim to investigate the anti-inflammatory mechanisms associated with the effects of RTA&#x02013;B in RAW264.7 macrophages and LO<sub>2</sub> cells by detecting cell viabilities, nitric oxide (NO) production, tumour necrosis factor-alpha (TNF-<italic>&#x003b1;</italic>), and interleukin-6 (IL-6) production. Simultaneously, the anti-inflammatory action mechanisms of these two compounds were illustrated through western blot assay. Besides, the antihepatic fibrosis activities of these compounds have also been explored. The results demonstrated that RTA and RTB inhibited the production of NO, TNF-<italic>&#x003b1;</italic>, and IL-6 and suppressed liver fibrosis. RTA and RTB treatment also greatly inhibited the activation of NF-kappaB (NF-<italic>&#x003ba;</italic>B) pathway. Our study confirmed the promising anti-inflammatory and anti-liver fibrosis actions of RTA&#x02013;B, suggesting that they might be developed as alternative and promising drugs for the treatment of hepatic inflammatory and fibrotic diseases.</p></abstract><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>81903509</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Inflammation is an immune response caused by tissue damages or pathogen infections [<xref rid="B1" ref-type="bibr">1</xref>]. Excessive and uncontrolled inflammations are harmful to the body, especially liver, the largest metabolic organ in the human body, as they may cause chronic diseases and further lead to fatty liver diseases, hepatitis, liver fibrosis, and even cirrhosis and liver cancer [<xref rid="B2" ref-type="bibr">2</xref>&#x02013;<xref rid="B6" ref-type="bibr">6</xref>]. Currently, the commercial drugs utilized to treat inflammation are mainly steroidal anti-inflammatory drugs (SAIDs) and nonsteroidal anti-inflammatory drugs (NSAIDs). However, with the increasing number of medical side effects discovered in clinical applications such as low potassium and hypertension [<xref rid="B7" ref-type="bibr">7</xref>&#x02013;<xref rid="B11" ref-type="bibr">11</xref>], novel inflammatory drugs are urgently needed [<xref rid="B12" ref-type="bibr">12</xref>]. Traditional diets, in particular, edible plants, with pharmacological functions such as pigeon pea, orange peel, and grapefruit [<xref rid="B13" ref-type="bibr">13</xref>&#x02013;<xref rid="B15" ref-type="bibr">15</xref>] have been always regarded as an essential source for treatment of inflammation. Therefore, it may be a potential way to seek new anti-inflammatory agents from traditional medicinal food [<xref rid="B16" ref-type="bibr">16</xref>].</p><p>
<italic>Rosa laevigata</italic> belonging to the Rosaceae family is widely distributed throughout southern China. Its fruits are recorded in Chinese Pharmacopoeia as a treatment for spermatorrhea, uroclepsia, frequent micturition, and uterine abscission and hence considered as a kind of traditional medicinal food in East Asia [<xref rid="B17" ref-type="bibr">17</xref>]. <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic>, a variety of <italic>R. laevigata</italic>, was firstly found and reported in Boluo county, Guangdong province, China, by Wang et al. in 1995 [<xref rid="B18" ref-type="bibr">18</xref>]. The specific morphological characteristics of this species attributed to its smooth fruits without any thorns. As a result of this distinction, <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic> can be developed as an alternative to <italic>R. laevigata</italic>, which can improve production efficiency and save labor costs, since there is no need to remove thorns from the fruit during harvesting and processing.</p><p>However, as characteristic constituents isolated from <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic> fruits [<xref rid="B19" ref-type="bibr">19</xref>], the bioactivity evaluations of rosanortriterpenes A&#x02013;B (RTA and RTB) (<xref ref-type="fig" rid="fig1">Figure 1</xref>) have rarely been reported. Therefore, studies on anti-inflammatory and antiliver fibrosis activities of RTA and RTB are presented in this paper.</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Reagents</title><p>RTA and RTB were isolated from <italic>R. laevigata</italic> var. <italic>leiocapus</italic> and stored in several small aliquots at &#x02212;80&#x000b0;C. Materials used for cell culture such as FBS (made in Australia), DMEM (made in China), PBS (pH 7.4), and penicillin/streptomycin were obtained from Gibco Company. The LPS (<italic>Escherichia coli</italic> 0127:B8), MTT powder, indomethacin (Indo), silibinin (SLB), and DMSO solvent were obtained from Sigma-Aldrich (St. Louis, MO, USA). TNF-<italic>&#x003b1;</italic> and TGF-<italic>&#x003b2;</italic> were obtained from PeproTech (Rocky Hill, NJ, USA). Griess reagent, DAF-FM DA, RIPA buffer, and BCA protein assay kits were purchased from Biotine (Shanghai, China). Nuclear protein extraction kits and Hoechst 33342 were purchased from Solarbio (Beijing, China). PVDF membranes were obtained from Millipore (Bedford, MA, USA). The NF-<italic>&#x003ba;</italic>B pathway sampler kit and <italic>&#x003b2;</italic>-actin rabbit antibodies were brought from Cell Signaling Technology Company (Danvers, MA, USA). The collagen I antibody, alpha-SMA antibody, and the enhanced chemiluminescence kit were obtained from Affinity Biosciences (Cincinnati, OH, USA). TNF-<italic>&#x003b1;</italic> and IL-6 enzyme immunoassay kits were purchased from Dakewe Biotech (Shenzhen, China).</p></sec><sec id="sec2.2"><title>2.2. Cell Line Culture</title><p>The RAW264.7 and HSC-T6 cells were gained from the CAS Cell Bank in Kunming. The LO<sub>2</sub> cells were purchased from the Chinese Academy of Sciences. The abovementioned cells were, respectively, cultured at 37&#x000b0;C in the DMEM medium system containing 10% FBS as well as 1% penicillin/streptomycin.</p></sec><sec id="sec2.3"><title>2.3. MTT Assays</title><p>Cytotoxicity assays were carried out utilizing a typical MTT method based on the standard protocol. To be brief, RAW264.7, LO<sub>2</sub>, and HSC-T6 cells were cultured in 96-well cell culture microplates with a density of 10<sup>4</sup>&#x02009;cells per well for LO<sub>2</sub> and HSC-T6 cells and 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup>&#x02009;cells per well for RAW264.7. After cell adhesion, 100&#x02009;<italic>&#x003bc;</italic>L of culture medium with established concentrations of RTA, RTB, or equal volume of DMSO replaced the original medium, and then, the cells were further incubated for 24&#x02009;h. 20&#x02009;<italic>&#x003bc;</italic>L of MTT (5&#x02009;mg/mL) was added to all wells and coincubated for 3&#x02009;h. After removing the medium, DMSO (150&#x02009;<italic>&#x003bc;</italic>L) was subjected to the wells to dissolve the formazan crystals. The solution was monitored using a microplate reader (Thermo, Massachusetts, USA) at 490&#x02009;nm.</p></sec><sec id="sec2.4"><title>2.4. NO Production Assay</title><p>RAW264.7 macrophages were dispensed in 96-well plates with a density of 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup>&#x02009;cells per well. After cell adhesion, different concentrations of RTA and RTB were added to the cell culture medium 2&#x02009;hours before LPS (100&#x02009;ng/mL) stimulation. After 24&#x02009;h, 100&#x02009;<italic>&#x003bc;</italic>L of Griess reagents A and B were added to the removed cell culture medium, respectively. The absorbance of the mixture was detected at 540&#x02009;nm using the aforementioned microplate reader.</p></sec><sec id="sec2.5"><title>2.5. Intracellular NO Assays</title><p>The fluorescence data of intracellular NO were also detected using a NO-sensitive fluorescence probe DAF-FM DA. Briefly, RAW264.7&#x02009;cells were dispensed in 96-well microplates with a density of 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup>&#x02009;cells per well, and RTA and RTB were added to the cell culture medium 2 hours before LPS stimulation after adhesion. After 24&#x02009;h incubation, cells were loaded with 10&#x02009;<italic>&#x003bc;</italic>M of DAF-FM DA for 40&#x02009;min at 37&#x000b0;C, then cells were carefully rinsed with PBS three times, and the data were recorded with 495&#x02009;nm as excitation wavelength and 515&#x02009;nm as emission wavelength using a microplate reader (Thermo, Massachusetts, USA).</p><p>The fluorescence microscopy imaging of intracellular NO was recorded utilizing DAF-FM DA. Similarly, RAW264.7 murine macrophages were dispensed in 96-well microplates with a density of 5&#x02009;&#x000d7;&#x02009;10<sup>4</sup>&#x02009;cells per well. After cell adhesion, RTA and RTB were added to the cell culture medium 2&#x02009;hours before LPS stimulation. After 24&#x02009;h incubation, cells were loaded with 10&#x02009;<italic>&#x003bc;</italic>M of DAF-FM DA for 40&#x02009;min at 37&#x000b0;C [<xref rid="B20" ref-type="bibr">20</xref>]. Then, cells were carefully rinsed by PBS for three times and then incubated for 30&#x02009;min with Hoechst 33342. Fluorescence was detected with a fluorescence microscope (BX-53, Olympus, Japan).</p></sec><sec id="sec2.6"><title>2.6. Western Blot Analysis</title><p>RAW264.7, LO<sub>2</sub>, and HSC-T6 cells were seeded in 6-well plates, and then different concentrations of RTA&#x02013;B were added to cells 2&#x02009;h before LPS (100&#x02009;ng/mL), TNF-<italic>&#x003b1;</italic> (20&#x02009;ng/mL), or TGF-<italic>&#x003b2;</italic> (10&#x02009;ng/mL) stimulation. After treatment for 24&#x02009;h, cells were collected to extract protein for further western blot analysis.</p></sec><sec id="sec2.7"><title>2.7. ELISA</title><p>The experimental protocol is based on the previous report; briefly, RAW 264.7&#x02009;cells and LO<sub>2</sub> were dispensed in 96-well plates, and RTA and RTB at prescribed concentrations were added to the culture medium 2&#x02009;h prior to LPS or TNF-<italic>&#x003b1;</italic> stimulation [<xref rid="B14" ref-type="bibr">14</xref>]. After 24&#x02009;h, productions of TNF-<italic>&#x003b1;</italic> or IL-6 in the cell culture medium were detected according to the instruction of manufacturers after dilution.</p></sec><sec id="sec2.8"><title>2.8. Statistical Analysis</title><p>The data in this work were expressed as mean&#x02009;&#x000b1;&#x02009;standard deviation (SD). One-way analysis of variance (ANOVA) together with Tukey multiple comparison tests were performed with GraphPad Prism 5 software.</p></sec></sec><sec id="sec3"><title>3. Results and Discussion</title><sec id="sec3.1"><title>3.1. Anti-Inflammatory Activities of RTA and RTB</title><sec id="sec3.1.1"><title>3.1.1. Cell Viability</title><p>Recruited myelo-derived free macrophages are important factors accounting for acute and chronic hepatitis [<xref rid="B21" ref-type="bibr">21</xref>]. Hence, two cell lines, RAW264.7 and LO<sub>2</sub>, were selected for the study on RTA and RTB for inflammation treatment. As a preliminary step, we tested their cytotoxicity against the two cells in 24&#x02009;h treatment duration. As a result, even at the concentration of 100&#x02009;<italic>&#x003bc;</italic>M, viabilities of the two cells treated with both RTA&#x02013;B were basically unchanged compared to the blank control group (Figures <xref ref-type="fig" rid="fig2">2(a)</xref> and <xref ref-type="fig" rid="fig2">2(b)</xref>), suggesting cytosafety of these compounds. In addition, we investigated the cell viability of LPS-stimulated RAW264.7 treated with RTA and RTB at the concentration of 3, 10, and 30&#x02009;<italic>&#x003bc;</italic>M with 10&#x02009;<italic>&#x003bc;</italic>M Indo acting as a positive control. The results are shown in <xref ref-type="fig" rid="fig2">Figure 2(c)</xref>. 100&#x02009;ng/mL LPS could stimulate the proliferation of RAW264.7; however, 24&#x02009;h treatment by RTA and RTB could reduce the proliferation in a dose-dependent manner.</p></sec><sec id="sec3.1.2"><title>3.1.2. NO Production Assay</title><p>RAW264.7 once stimulated by LPS will generate a great amount of NO which is one of the active radical species [<xref rid="B22" ref-type="bibr">22</xref>]. Excessive NO in return may greatly facilitate cascade reactions of inflammation [<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B23" ref-type="bibr">23</xref>]. It has been widely accepted that LPS stimulation can significantly increase NO release in macrophages. In order to study the anti-inflammatory activities of RTA&#x02013;B, we applied them to RAW264.7&#x02009;cells stimulated by LPS to measure their effects on NO production and Indo was still chosen as a positive control. <xref ref-type="fig" rid="fig3"> Figure 3(a)</xref> displays a dosage-dependent NO production inhibition effects of the compounds. In terms of intracellular NO, consistent with the previous results, these compounds could inhibit the production of intracellular NO represented by the fluorescence intensity (<xref ref-type="fig" rid="fig3">Figure 3(b)</xref>). And as for intracellular NO microscopy imaging, for all groups, the blue fluorescence representing living cells stained by Hoechst 33342 remained almost stable. The control group showed weak green fluorescence representing intracellular NO. In contrast, cells treated by LPS exhibited strong green fluorescence. However, green fluorescence significantly weakened by RTA and RTB treatment implying their potential for anti-inflammatory activities (<xref ref-type="fig" rid="fig3">Figure 3(c)</xref>).</p></sec><sec id="sec3.1.3"><title>3.1.3. Inhibition of NF-kB Activation by RTA and RTB</title><p>NF-<italic>&#x003ba;</italic>B is one of the most significant signal pathways regulating proinflammatory genes whose productions in return give rise in the persistent activation of NF-<italic>&#x003ba;</italic>B pathway and further exacerbate inflammatory response [<xref rid="B24" ref-type="bibr">24</xref>]. In resting cells, NF-<italic>&#x003ba;</italic>B is normally present in the cytoplasm in formation as an inactive I<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic>/<italic>p</italic>50/<italic>p</italic>65 heterotrimer. Stimulated by activators such as LPS or TNF-<italic>&#x003b1;</italic>, IKK<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic> is phosphorylated and activated IKK<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic> triggers phosphorylation of I<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic> and release of p65 from the complex [<xref rid="B25" ref-type="bibr">25</xref>]. Dissociative p65 once translocated into the nucleus would initiate transcription of downstream genes inducing those coding proinflammatory cytokines [<xref rid="B26" ref-type="bibr">26</xref>]. To determine whether RTA and RTB achieve their anti-inflammatory effects via NF-<italic>&#x003ba;</italic>B pathway, western blot analysis was launched to identify expressions of related proteins. <xref ref-type="fig" rid="fig4"> Figure 4(a)</xref> shows that compared with the blank control group, the productions of p-IKK<italic>&#x003b1;</italic>/<italic>&#x003b2;</italic> and p-p65 along with p-I<italic>&#x003ba;</italic>B<italic>&#x003b1;</italic> in total lysate and p65 in the nucleus were significantly increased in the LPS-model group, while RTA and RTB remarkably suppressed the levels of these proteins in RAW264.7&#x02009;cells. Similarly, the increase of p-p65 induced by TNF-<italic>&#x003b1;</italic> was also inhibited by RTA and RTB in LO<sub>2</sub> cells. Consistent with our expectations, both RTA and RTB showed suppression of activated NF-<italic>&#x003ba;</italic>B pathway both in macrophages and hepatic cells.</p></sec><sec id="sec3.1.4"><title>3.1.4. Inhibition of TNF-<italic>&#x003b1;</italic> and IL-6 Production by RTA and RTB</title><p>TNF-<italic>&#x003b1;</italic> and IL-6 are two essential proinflammatory cytokines in inflammation, and their high expressions are commonly found in liver injuries [<xref rid="B27" ref-type="bibr">27</xref>&#x02013;<xref rid="B29" ref-type="bibr">29</xref>]. In order to further clarify the anti-inflammatory effects of RTA and RTB, we detected the productions of these two proinflammatory cytokines in LPS-stimulated RAW264.7 and IL-6 in TNF-<italic>&#x003b1;</italic>-stimulated LO<sub>2</sub>. The results are displayed in <xref ref-type="fig" rid="fig5">Figure 5</xref>. The productions of TNF-<italic>&#x003b1;</italic> and IL-6 in the medium supernatant after treatment with different concentrations of RTA or RTB were lower than those only treated with LPS in a dose-dependent manner proving that these two compounds could reduce the productions of critical proinflammatory cytokines.</p></sec></sec><sec id="sec3.2"><title>3.2. Antifibrotic Activities of RTA and RTB</title><sec id="sec3.2.1"><title>3.2.1. Cell Viability</title><p>In order to explore whether the compounds have antifibrotic activities in hepatic cells, we first tested their cytotoxicity against hepatic stellate cells, HSC-T6. Consistent with previous results, after 24&#x02009;h treatment, viabilities of HSC-T6 treated by both compounds showed no significant differences compared to the blank control group even at the concentration of 100&#x02009;<italic>&#x003bc;</italic>M (<xref ref-type="fig" rid="fig6">Figure 6(a)</xref>). Additionally, we further investigated the cell viability of TGF-<italic>&#x003b2;</italic>-stimulated HSC-T6 treated by RTA and RTB at the concentration of 3, 10, and 30&#x02009;<italic>&#x003bc;</italic>M with 10&#x02009;<italic>&#x003bc;</italic>M SLB acting as a positive control. The results are shown in <xref ref-type="fig" rid="fig6">Figure 6(b)</xref>. Stimulated by TGF-<italic>&#x003b2;</italic>, proliferation of HSC-T6 increased significantly; however, 24&#x02009;h treatment by RTA and RTB could reduce the proliferation in a dose-dependent manner.</p></sec><sec id="sec3.2.2"><title>3.2.2. Western Blot Analysis</title><p>Liver fibrosis is characterized by excess deposition of extracellular matrix (ECM) such as collagen type-I (Col1) and <italic>&#x003b1;</italic>-smooth muscle actin (<italic>&#x003b1;</italic>-SMA) [<xref rid="B30" ref-type="bibr">30</xref>]. So we detected the effect of the compounds on the expression of the above proteins, and results are shown in <xref ref-type="fig" rid="fig7">Figure 7</xref>. After 24&#x02009;h treatment, both RTA and RTB could inhibit the increase of ECM-related proteins stimulated by TGF-<italic>&#x003b2;</italic> in a dose-dependent manner. Besides, NF-<italic>&#x003ba;</italic>B is also an important signaling pathway in the development of liver fibrosis that not only participates in the proliferation and apoptosis of liver cells but also promotes activation of hepatic stellate cells [<xref rid="B31" ref-type="bibr">31</xref>]. In HSC-T6 cells stimulated by TGF-<italic>&#x003b2;</italic>, the p-p65 was significantly increased, as well as p65 in nucleus. While under the treatment of the compounds, the levels of these two proteins decreased indicating that RTA and RTB could suppress NF-kB activation and ECM deposition induced by TGF-<italic>&#x003b2;</italic> in hepatic stellate cells.</p></sec></sec></sec><sec id="sec4"><title>4. Conclusions</title><p>In various cultures around the world, inflammation and relative diseases have always been treated by plant and plant-derived agents [<xref rid="B32" ref-type="bibr">32</xref>]. Among them, fruits of <italic>Rosaceae</italic> were reported to possess potential anti-inflammatory activities [<xref rid="B33" ref-type="bibr">33</xref>&#x02013;<xref rid="B35" ref-type="bibr">35</xref>]. As a potential substitute for <italic>R. laevigata</italic>, the convenience of <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic> in the food processing makes it more favorable to serve as a medicinal food source. In addition, the COVID-19 epidemic has seriously affected the world's political and economic patterns leading to food insecurity [<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>]; hence, seeking and making full use of food resources with pharmacological values seems more significant in the current crisis. Thus, the medicinal values of <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic> need to be determined urgently. In this present study, the anti-inflammatory and anti&#x02010;liver fibrosis effects of two characteristic compounds from <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic>, RTA and RTB, were elaborated. Taking together, our work not only lays a foundation for the development and application of <italic>Rosa laevigata</italic> var. <italic>leiocapus</italic> but also provides dietary supplements targeting at liver inflammation and fibrosis.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was financially supported by the National Natural Science Foundation (No. 81903509).</p></ack><sec sec-type="data-availability"><title>Data Availability</title><p>The materials and data presented in the work are available from the authors upon reasonable request.</p></sec><sec sec-type="COI-statement"><title>Conflicts of Interest</title><p>All authors declare that there are no conflicts of interest.</p></sec><sec><title>Authors' Contributions</title><p>Bai-Lin Lia and Juan-Juan Hua contributed equally to this work.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>K. R.</given-names></name><name><surname>Ling</surname><given-names>P.</given-names></name></person-group><article-title>Emerging roles of an innate immune regulator TAPE in toll-like receptors, RIG-I-like receptors, and beyond</article-title><source><italic toggle="yes">European Journal of Immunology</italic></source><year>2016</year><volume>46</volume><fpage>p. 646</fpage></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Karin</surname><given-names>M.</given-names></name></person-group><article-title>Obesity, inflammation, and liver cancer</article-title><source><italic toggle="yes">Journal of Hepatology</italic></source><year>2012</year><volume>56</volume><issue>3</issue><fpage>704</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2011.09.020</pub-id><pub-id pub-id-type="other">2-s2.0-84856429876</pub-id><pub-id pub-id-type="pmid">22120206</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tilg</surname><given-names>H.</given-names></name><name><surname>Moschen</surname><given-names>A. R.</given-names></name></person-group><article-title>Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis</article-title><source><italic toggle="yes">Hepatology</italic></source><year>2010</year><volume>52</volume><issue>5</issue><fpage>1836</fpage><lpage>1846</lpage><pub-id pub-id-type="doi">10.1002/hep.24001</pub-id><pub-id pub-id-type="other">2-s2.0-78049522194</pub-id><pub-id pub-id-type="pmid">21038418</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takeda</surname><given-names>H.</given-names></name><name><surname>Takai</surname><given-names>A.</given-names></name><name><surname>Inuzuka</surname><given-names>T.</given-names></name><name><surname>Marusawa</surname><given-names>H.</given-names></name></person-group><article-title>Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis</article-title><source><italic toggle="yes">Journal of Gastroenterology</italic></source><year>2017</year><volume>52</volume><issue>1</issue><fpage>26</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1007/s00535-016-1273-2</pub-id><pub-id pub-id-type="other">2-s2.0-84990822454</pub-id><pub-id pub-id-type="pmid">27714455</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iredale</surname><given-names>J. P.</given-names></name></person-group><article-title>Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ</article-title><source><italic toggle="yes">Journal of Clinical Investigation</italic></source><year>2007</year><volume>117</volume><issue>3</issue><fpage>539</fpage><lpage>548</lpage><pub-id pub-id-type="doi">10.1172/jci30542</pub-id><pub-id pub-id-type="other">2-s2.0-33847363203</pub-id><pub-id pub-id-type="pmid">17332881</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baig</surname><given-names>M. S.</given-names></name><name><surname>Zaichick</surname><given-names>S. V.</given-names></name><name><surname>Mao</surname><given-names>M.</given-names></name><etal/></person-group><article-title>NOS1-derived nitric oxide promotes NF-<italic>&#x003ba;</italic>B transcriptional activity through inhibition of suppressor of cytokine signaling-1</article-title><source><italic toggle="yes">Journal of Experimental Medicine</italic></source><year>2015</year><volume>212</volume><issue>10</issue><fpage>1725</fpage><lpage>1738</lpage><pub-id pub-id-type="doi">10.1084/jem.20140654</pub-id><pub-id pub-id-type="other">2-s2.0-84961216724</pub-id><pub-id pub-id-type="pmid">26324446</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harirforoosh</surname><given-names>S.</given-names></name><name><surname>Asghar</surname><given-names>W.</given-names></name><name><surname>Jamali</surname><given-names>F.</given-names></name></person-group><article-title>Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications</article-title><source><italic toggle="yes">Journal of pharmacy &#x00026;amp; pharmaceutical sciences :a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques</italic></source><year>2013</year><volume>16</volume><issue>5</issue><fpage>821</fpage><lpage>847</lpage></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirmohamed</surname><given-names>M.</given-names></name><name><surname>James</surname><given-names>S.</given-names></name><name><surname>Meakin</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients</article-title><source><italic toggle="yes">British medical journal</italic></source><year>2004</year><volume>329</volume><issue>7456</issue><fpage>15</fpage><lpage>19</lpage><pub-id pub-id-type="doi">10.1136/bmj.329.7456.15</pub-id><pub-id pub-id-type="pmid">15231615</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rooney</surname><given-names>P. J.</given-names></name><name><surname>Hunt</surname><given-names>R. H.</given-names></name></person-group><article-title>The risk of upper gastrointestinal haemorrhage during steroidal and non-steroidal anti-inflammatory therapy</article-title><source><italic toggle="yes">Bailli&#x000e8;re&#x02019;s Clinical Rheumatology</italic></source><year>1990</year><volume>4</volume><issue>2</issue><fpage>207</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/s0950-3579(05)80018-4</pub-id><pub-id pub-id-type="other">2-s2.0-0025678315</pub-id><pub-id pub-id-type="pmid">2032297</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Warner</surname><given-names>T. D.</given-names></name><name><surname>Giuliano</surname><given-names>F.</given-names></name><name><surname>Vojnovic</surname><given-names>I.</given-names></name><name><surname>Bukasa</surname><given-names>A.</given-names></name><name><surname>Mitchell</surname><given-names>J. A.</given-names></name><name><surname>Vane</surname><given-names>J. R.</given-names></name></person-group><article-title>Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis</article-title><source><italic toggle="yes">Proceedings of the National Academy of Sciences</italic></source><year>1999</year><volume>96</volume><issue>13</issue><fpage>7563</fpage><lpage>7568</lpage><pub-id pub-id-type="doi">10.1073/pnas.96.13.7563</pub-id><pub-id pub-id-type="other">2-s2.0-0033594911</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>S. L.</given-names></name><name><surname>Poulter</surname><given-names>N. R.</given-names></name></person-group><article-title>The effect of non-steroidal anti-inflammatory drugs and other commonly used non-narcotic analgesics on blood pressure level in adults</article-title><source><italic toggle="yes">Journal of Hypertension</italic></source><year>2006</year><volume>24</volume><issue>8</issue><fpage>1457</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1097/01.hjh.0000239278.82196.a5</pub-id><pub-id pub-id-type="other">2-s2.0-33746777182</pub-id><pub-id pub-id-type="pmid">16877945</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Botz</surname><given-names>B.</given-names></name><name><surname>Bolcskei</surname><given-names>K.</given-names></name><name><surname>Helyes</surname><given-names>Z.</given-names></name></person-group><article-title>Challenges to develop novel anti-inflammatory and analgesic drugs</article-title><source><italic toggle="yes">Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology</italic></source><year>2017</year><volume>9</volume><issue>3</issue><pub-id pub-id-type="doi">10.1002/wnan.1427</pub-id><pub-id pub-id-type="other">2-s2.0-84984675539</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ignat</surname><given-names>I.</given-names></name><name><surname>Volf</surname><given-names>I.</given-names></name><name><surname>Popa</surname><given-names>V. I.</given-names></name></person-group><article-title>A critical review of methods for characterisation of polyphenolic compounds in fruits and vegetables</article-title><source><italic toggle="yes">Food Chemistry</italic></source><year>2011</year><volume>126</volume><issue>4</issue><fpage>1821</fpage><lpage>1835</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2010.12.026</pub-id><pub-id pub-id-type="other">2-s2.0-79551573834</pub-id><pub-id pub-id-type="pmid">25213963</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M.-Y.</given-names></name><name><surname>Lin</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Anti-inflammatory effects of cajaninstilbene acid and its derivatives</article-title><source><italic toggle="yes">Journal of Agricultural and Food Chemistry</italic></source><year>2016</year><volume>64</volume><issue>14</issue><fpage>2893</fpage><lpage>2900</lpage><pub-id pub-id-type="doi">10.1021/acs.jafc.6b00227</pub-id><pub-id pub-id-type="other">2-s2.0-84964649326</pub-id><pub-id pub-id-type="pmid">26998619</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galati</surname><given-names>E. M.</given-names></name></person-group><article-title>Biological effects of hesperidin, a citrus flavonoid .1. antiinflammatory and analgesic activity</article-title><source><italic toggle="yes">Farmaco</italic></source><year>1994</year><volume>49</volume><issue>11</issue><fpage>709</fpage><lpage>712</lpage></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maione</surname><given-names>F.</given-names></name><name><surname>Russo</surname><given-names>R.</given-names></name><name><surname>Khan</surname><given-names>H.</given-names></name><name><surname>Mascolo</surname><given-names>N.</given-names></name></person-group><article-title>Medicinal plants with anti-inflammatory activities</article-title><source><italic toggle="yes">Natural Product Research</italic></source><year>2016</year><volume>30</volume><issue>12</issue><fpage>1343</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.1080/14786419.2015.1062761</pub-id><pub-id pub-id-type="other">2-s2.0-84939155042</pub-id><pub-id pub-id-type="pmid">26221780</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuan</surname><given-names>J.-Q.</given-names></name><name><surname>Yang</surname><given-names>X.-Z.</given-names></name><name><surname>Miao</surname><given-names>J.-H.</given-names></name><etal/></person-group><article-title>New triterpene glucosides from the roots of Rosa laevigata michx</article-title><source><italic toggle="yes">Molecules</italic></source><year>2008</year><volume>13</volume><issue>9</issue><fpage>2229</fpage><lpage>2237</lpage><pub-id pub-id-type="doi">10.3390/molecules13092229</pub-id><pub-id pub-id-type="other">2-s2.0-53249149415</pub-id><pub-id pub-id-type="pmid">18830152</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yingqiang</surname><given-names>W.</given-names></name><name><surname>Pngyu</surname><given-names>C.</given-names></name></person-group><article-title>New taxa of guangdong plants</article-title><source><italic toggle="yes">Journal of Tropical &#x00026; Subtropical Botan</italic></source><year>1995</year><volume>3</volume><fpage>27</fpage><lpage>33</lpage></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>Y. N.</given-names></name><name><surname>Rosanortriterpenes</surname><given-names>A.-B.</given-names></name></person-group><article-title>Two new nortriterpenes from the fruits of rosa laevigata var. leiocapus</article-title><source><italic toggle="yes">Natural Product Research</italic></source><year>2019</year><fpage>8</fpage></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barp</surname><given-names>C. G.</given-names></name><name><surname>Mendes</surname><given-names>C.</given-names></name><name><surname>Lemos-Senna</surname><given-names>E.</given-names></name><name><surname>Assreuy</surname><given-names>J.</given-names></name></person-group><article-title>7-nitroindazol-loaded nanoemulsions: preparation, characterization and its improved inhibitory effect on nitric oxide synthase-1</article-title><source><italic toggle="yes">Nitric Oxide</italic></source><year>2018</year><volume>76</volume><fpage>129</fpage><lpage>135</lpage><pub-id pub-id-type="doi">10.1016/j.niox.2017.09.003</pub-id><pub-id pub-id-type="other">2-s2.0-85030108072</pub-id><pub-id pub-id-type="pmid">28943472</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenner</surname><given-names>C.</given-names></name><name><surname>Galluzzi</surname><given-names>L.</given-names></name><name><surname>Kepp</surname><given-names>O.</given-names></name><name><surname>Kroemer</surname><given-names>G.</given-names></name></person-group><article-title>Decoding cell death signals in liver inflammation</article-title><source><italic toggle="yes">Journal of Hepatology</italic></source><year>2013</year><volume>59</volume><issue>3</issue><fpage>583</fpage><lpage>594</lpage><pub-id pub-id-type="doi">10.1016/j.jhep.2013.03.033</pub-id><pub-id pub-id-type="other">2-s2.0-84882827495</pub-id><pub-id pub-id-type="pmid">23567086</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaki</surname><given-names>M. H.</given-names></name><name><surname>Akuta</surname><given-names>T.</given-names></name><name><surname>Akaike</surname><given-names>T.</given-names></name></person-group><article-title>Nitric oxide-induced nitrative stress involved in microbial pathogenesis</article-title><source><italic toggle="yes">Journal of Pharmacological Sciences</italic></source><year>2005</year><volume>98</volume><issue>2</issue><fpage>117</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1254/jphs.crj05004x</pub-id><pub-id pub-id-type="other">2-s2.0-21744434507</pub-id><pub-id pub-id-type="pmid">15937405</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ohshima</surname><given-names>H.</given-names></name><name><surname>Bartsch</surname><given-names>H.</given-names></name></person-group><article-title>Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis</article-title><source><italic toggle="yes">Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis</italic></source><year>1994</year><volume>305</volume><issue>2</issue><fpage>253</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/0027-5107(94)90245-3</pub-id><pub-id pub-id-type="other">2-s2.0-0028218474</pub-id><pub-id pub-id-type="pmid">7510036</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sano</surname><given-names>C.</given-names></name><name><surname>Shimizu</surname><given-names>T.</given-names></name><name><surname>Tomioka</surname><given-names>H.</given-names></name></person-group><article-title>Effects of secretory leukocyte protease inhibitor on the tumor necrosis factor-alpha production and NF-<italic>&#x003ba;</italic>B activation of lipopolysaccharide-stimulated macrophages</article-title><source><italic toggle="yes">Cytokine</italic></source><year>2003</year><volume>21</volume><issue>1</issue><fpage>38</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/s1043-4666(02)00485-4</pub-id><pub-id pub-id-type="other">2-s2.0-0037422706</pub-id><pub-id pub-id-type="pmid">12668158</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>Y.</given-names></name><name><surname>Gaynor</surname><given-names>R. B.</given-names></name></person-group><article-title>I<italic>&#x003ba;</italic>B kinases: key regulators of the NF-<italic>&#x003ba;</italic>B pathway</article-title><source><italic toggle="yes">Trends in Biochemical Sciences</italic></source><year>2004</year><volume>29</volume><issue>2</issue><fpage>72</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1016/j.tibs.2003.12.003</pub-id><pub-id pub-id-type="other">2-s2.0-0442307969</pub-id><pub-id pub-id-type="pmid">15102433</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>S.</given-names></name><name><surname>Hayden</surname><given-names>M. S.</given-names></name></person-group><article-title>New regulators of NF-<italic>&#x003ba;</italic>B in inflammation</article-title><source><italic toggle="yes">Nature Reviews Immunology</italic></source><year>2008</year><volume>8</volume><issue>11</issue><fpage>837</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1038/nri2423</pub-id><pub-id pub-id-type="other">2-s2.0-54949147176</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>B.</given-names></name></person-group><article-title>Hepatoprotective and anti-inflammatory cytokines in alcoholic liver disease</article-title><source><italic toggle="yes">Journal of Gastroenterology and Hepatology</italic></source><year>2012</year><volume>27</volume><fpage>89</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1746.2011.07003.x</pub-id><pub-id pub-id-type="other">2-s2.0-84856948223</pub-id><pub-id pub-id-type="pmid">22320924</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Zayadi</surname><given-names>A.-R.</given-names></name></person-group><article-title>Heavy smoking and liver</article-title><source><italic toggle="yes">World Journal of Gastroenterology</italic></source><year>2006</year><volume>12</volume><issue>38</issue><fpage>6098</fpage><lpage>6101</lpage><pub-id pub-id-type="doi">10.3748/wjg.v12.i38.6098</pub-id><pub-id pub-id-type="other">2-s2.0-33750625885</pub-id><pub-id pub-id-type="pmid">17036378</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sheng</surname><given-names>Y.</given-names></name><name><surname>Ma</surname><given-names>Y.</given-names></name><name><surname>Deng</surname><given-names>Z.</given-names></name><name><surname>Wang</surname><given-names>Z.</given-names></name><name><surname>Ji</surname><given-names>L.</given-names></name></person-group><article-title>Cytokines as potential biomarkers of liver toxicity induced by dioscorea bulbifera L</article-title><source><italic toggle="yes">Bioscience Trends</italic></source><year>2014</year><volume>8</volume><issue>1</issue><fpage>32</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.5582/bst.8.32</pub-id><pub-id pub-id-type="other">2-s2.0-84896889977</pub-id><pub-id pub-id-type="pmid">24647110</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Friedman</surname><given-names>S. L.</given-names></name></person-group><article-title>Mechanisms of hepatic fibrogenesis</article-title><source><italic toggle="yes">Gastroenterology</italic></source><year>2008</year><volume>134</volume><issue>6</issue><fpage>1655</fpage><lpage>1669</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2008.03.003</pub-id><pub-id pub-id-type="other">2-s2.0-42949163491</pub-id><pub-id pub-id-type="pmid">18471545</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elsharkawy</surname><given-names>A. M.</given-names></name><name><surname>Mann</surname><given-names>D. A.</given-names></name></person-group><article-title>Nuclear factor-<italic>&#x003ba;</italic>B and the hepatic inflammation-fibrosis-cancer axis</article-title><source><italic toggle="yes">Hepatology</italic></source><year>2007</year><volume>46</volume><issue>2</issue><fpage>590</fpage><lpage>597</lpage><pub-id pub-id-type="doi">10.1002/hep.21802</pub-id><pub-id pub-id-type="other">2-s2.0-34548321204</pub-id><pub-id pub-id-type="pmid">17661407</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mueller</surname><given-names>M.</given-names></name><name><surname>Hobiger</surname><given-names>S.</given-names></name><name><surname>Jungbauer</surname><given-names>A.</given-names></name></person-group><article-title>Anti-inflammatory activity of extracts from fruits, herbs and spices</article-title><source><italic toggle="yes">Food Chemistry</italic></source><year>2010</year><volume>122</volume><issue>4</issue><fpage>987</fpage><lpage>996</lpage><pub-id pub-id-type="doi">10.1016/j.foodchem.2010.03.041</pub-id><pub-id pub-id-type="other">2-s2.0-77951939535</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choi</surname><given-names>E.-M.</given-names></name><name><surname>Hwang</surname><given-names>J.-K.</given-names></name></person-group><article-title>Investigations of anti-inflammatory and antinociceptive activities of piper cubeba, physalis angulata and rosa hybrida</article-title><source><italic toggle="yes">Journal of Ethnopharmacology</italic></source><year>2003</year><volume>89</volume><issue>1</issue><fpage>171</fpage><lpage>175</lpage><pub-id pub-id-type="doi">10.1016/s0378-8741(03)00280-0</pub-id><pub-id pub-id-type="other">2-s2.0-0141792341</pub-id><pub-id pub-id-type="pmid">14522451</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>Y.</given-names></name><name><surname>Han</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Potent effects of flavonoid-rich extract from rosa laevigata michx fruit against hydrogen peroxide-induced damage in PC12 cells via attenuation of oxidative stress, inflammation and apoptosis</article-title><source><italic toggle="yes">Molecules</italic></source><year>2014</year><volume>19</volume><issue>8</issue><fpage>11816</fpage><lpage>11832</lpage><pub-id pub-id-type="doi">10.3390/molecules190811816</pub-id><pub-id pub-id-type="other">2-s2.0-84906657499</pub-id><pub-id pub-id-type="pmid">25105919</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tao</surname><given-names>X.</given-names></name><name><surname>Sun</surname><given-names>X.</given-names></name><name><surname>Xu</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Total flavonoids from rosa laevigata michx fruit ameliorates hepatic ischemia/reperfusion injury through inhibition of oxidative stress and inflammation in rats</article-title><source><italic toggle="yes">Nutrients</italic></source><year>2016</year><volume>8</volume><issue>7</issue><fpage>418</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.3390/nu8070418</pub-id><pub-id pub-id-type="other">2-s2.0-84978517041</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haghani</surname><given-names>M.</given-names></name><name><surname>Michiel</surname><given-names>C. J. B.</given-names></name><name><surname>Goerlandt</surname><given-names>F.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name></person-group><article-title>The scientific literature on corona viruses, COVID-19 and its associated safety-related research dimensions: a scientometric analysis and scoping review</article-title><source><italic toggle="yes">Safety Science</italic></source><year>2020</year><volume>129</volume><pub-id pub-id-type="publisher-id">104806</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leddy</surname><given-names>A. M.</given-names></name><name><surname>Weiser</surname><given-names>S. D.</given-names></name><name><surname>Palar</surname><given-names>K.</given-names></name><name><surname>Seligman</surname><given-names>H.</given-names></name></person-group><article-title>A conceptual model for understanding the rapid COVID-19-related increase in food insecurity and its impact on health and healthcare</article-title><source><italic toggle="yes">The American Journal of Clinical Nutrition</italic></source><year>2020</year></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Structures of compounds RTA and RTB.</p></caption><graphic xlink:href="ECAM2020-8872945.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Effects of RTA and RTB on cell viabilities of (a) RAW264.7 and (b) LO<sub>2</sub>. <sup><italic>&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.05 and <sup><italic>&#x02217;&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.01 compound treatment groups vs. DMSO group. (c) Effects of RTA and RTB on cell viabilities of RAW264.7 stimulated by LPS (100&#x02009;ng/mL). <sup><italic>&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.05 and <sup><italic>&#x02217;&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.01 compound treatment groups vs. LPS group.</p></caption><graphic xlink:href="ECAM2020-8872945.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Effects of RTA&#x02013;B on NO production. (a) Inhibitory effects of RTA and RTB on NO production of RAW264.7 murine macrophages stimulated with LPS (100&#x02009;ng/mL). (b) Fluorescence data of intracellular NO of RAW264.7. <sup><italic>&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.05 and <sup><italic>&#x02217;&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.01 compound treatment groups vs. LPS group. (c) Intracellular NO microscopy imaging of RAW264.7, blue for the nucleus of living cells and green for intracellular NO with&#x02009;&#x000d7;&#x02009;20 magnification.</p></caption><graphic xlink:href="ECAM2020-8872945.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Detraction influences of RTA&#x02013;B on protein expressions in NF-<italic>&#x003ba;</italic>B pathway in (a) RAW264.7&#x02009;cells stimulated by LPS (100&#x02009;ng/mL) and (b) LO2 cells stimulated by TNF-<italic>&#x003b1;</italic> (20&#x02009;ng/mL). <sup><italic>&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.05 and <sup><italic>&#x02217;&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.01 compound treatment groups vs. model group.</p></caption><graphic xlink:href="ECAM2020-8872945.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>Detraction influences of RTA&#x02013;B on (a) TNF-<italic>&#x003b1;</italic> in RAW264.7 stimulated by LPS (100&#x02009;ng/mL), (b) IL-6 levels in RAW264.7 stimulated by LPS (100&#x02009;ng/mL), and (c) IL-6 levels in LO<sub>2</sub> stimulated by TNF-<italic>&#x003b1;</italic> (20&#x02009;ng/mL). <sup><italic>&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.05 and <sup><italic>&#x02217;&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.01 compound treatment groups vs. model group.</p></caption><graphic xlink:href="ECAM2020-8872945.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>Effects of RTA and RTB on cell viabilities of (a) HSC-T6. <sup><italic>&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.05 and <sup><italic>&#x02217;&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.01 compound treatment groups vs. DMSO group. (b) Effects of RTA and RTB on cell viabilities of HSC-T6 stimulated by TGF-<italic>&#x003b2;</italic> (10&#x02009;ng/mL). <sup><italic>&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.05 and <sup><italic>&#x02217;&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.01 compound treatment groups vs. TGF-<italic>&#x003b2;</italic> group.</p></caption><graphic xlink:href="ECAM2020-8872945.006"/></fig><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>Influences of RTA&#x02013;B on fibrosis-related protein expressions in HSC-T6 cells stimulated by TGF-<italic>&#x003b2;</italic> (10&#x02009;ng/mL). <sup><italic>&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.05 and <sup><italic>&#x02217;&#x02217;</italic></sup><italic>p</italic> &#x0003c; 0.01 compound treatment groups vs. model group.</p></caption><graphic xlink:href="ECAM2020-8872945.007"/></fig></floats-group></article>